ISQ Global Fund II GP LLC (Wahba Sadek, Bhandari Gautam) sold $14.3M of KNTK (indirect holdings)
ISQ Global Fund II GP LLC sold 265,572 indirectly-held shares of Kinetik Holdings Inc. (KNTK) at an average of $54.03 ($53.59–$54.72, $14.35M total) across 4 trades over 2026-09-17 to 2026-09-21. Filed jointly with I Squared Capital, LLC (10% owner), ISQ Holdings, LLC (10% owner), Wahba Sadek (10% owner) and Bhandari Gautam (10% owner).
How this was made
The 30-second read
Why it matters
The disclosed sale reduces insider ownership, which may be interpreted by the market as reduced confidence.
Market read
Primary insider sell; modest trading relevance for short‑term investors.
What to watch
Potential upcoming catalyst such as a clinical trial update may offset the sell pressure.
Background
SEC Form 4 filings provide the first public disclosure of insider transactions.
Ticker impact
Form 4 disclosed a $14.3M open‑market sale by a 10% owner, reducing holdings to 448,273 shares.
Possible modest downside of 2‑4% over the next few days.
Insider sold ~265k shares at $54 average, a sizable stake for a micro‑cap; such sales often precede price weakness.
Market effects
Minimal; the sale is company‑specific and does not affect the broader biotech sector.
None; the transaction is confined to US investors.
Low; no cross‑border or macro implications.
Counterpoint
The sale could be a routine liquidity event rather than a bearish signal.
Key entities
- CompanyKinetik Holdings Inc.
US‑listed biotech firm (ticker KNTK).
- InsiderISQ Global Fund II GP LLC
10% owner reporting the sale.
